Disrupting Cancer Diagnostics - Cloud-based Deep Learning AI for - - PowerPoint PPT Presentation

disrupting cancer diagnostics cloud based deep learning
SMART_READER_LITE
LIVE PREVIEW

Disrupting Cancer Diagnostics - Cloud-based Deep Learning AI for - - PowerPoint PPT Presentation

Disrupting Cancer Diagnostics - Cloud-based Deep Learning AI for Gigantic Pathology Images Kaisa Helminen, CEO Fimmic Oy May 11th, 2017 Cancer Every third person affected 14 Million new patients in 2012 +50% more by 2030 Increasing number


slide-1
SLIDE 1

Disrupting Cancer Diagnostics - Cloud-based Deep Learning AI for Gigantic Pathology Images

Kaisa Helminen, CEO Fimmic Oy May 11th, 2017

slide-2
SLIDE 2

Every third person affected 14 Million new patients in 2012 +50% more by 2030

Cancer

Increasing number of samples

slide-3
SLIDE 3

Problem

Lack of pathologists Increasing number of samples

Gap!

slide-4
SLIDE 4

Subjective, manual analysis

Microscopy in cancer diagnostics

Risk for misdiagnosis and wrong medication Agreement can be as low as 48%

slide-5
SLIDE 5

Digitalization

  • >

Deep Learning AI

slide-6
SLIDE 6

Gigapixel-sized files (Gb-Tb) Locked image file formats Image Analysis software are expensive

  • n-premise installations

Conventional machine vision technology is limited

Challenges

designed by Freepik

slide-7
SLIDE 7

Samples

WebMicroscope Workflow

Artificial Intelligence

Pathologists Researchers Any microscope scanner Educators Any device

slide-8
SLIDE 8

Artificial Intelligence & Deep Learning

Facial recognition

id-labs.org The Guardian

Self-driving cars Tissue diagnostics

slide-9
SLIDE 9

Different types of Deep Learning Image Analysis tasks

  • 1. Laborious quantification tasks, combined with ROI selection, e.g.

quantification of certain cells

  • 2. Segmentation of tissue based on morphology, e.g. tumor grading,

epithelium/stroma segmentation

  • 3. Detecting and quantifying rare targets, e.g. infectious agents, forensic

samples

slide-10
SLIDE 10

Application example 1 - Quantification task

Breast cancer diagnostics, Quantification of Ki67+ cells from epithelium

slide-11
SLIDE 11
  • 1. Epithelium-stroma

segmentation

  • 2. Quantification of Ki67 + and -

cells inside the epithelium

slide-12
SLIDE 12

Negative and weak signals Moderate and Strong

slide-13
SLIDE 13

Context-intelligent Image Analysis

Enables full automation Removes extra staining step

  • > Saves time

Accurate Reproducible

  • > Supports correct diagnosis
slide-14
SLIDE 14
slide-15
SLIDE 15

Application example 2: Automated segmentation of cancer tissue TMA slides, prostate cancer

Tissue Microarray

slide-16
SLIDE 16

Application example 2 - Automated segmentation task

Prostate cancer, Segmentation of cancer tissue, area quantification

slide-17
SLIDE 17

Application example 3 - Quantification task

Testicular Cancer, Quantification of tumor infiltrating lymphocytes (TIL%)

H&E of immune cell rich region Heat map showing immune cell detec7on

FIMM – Oxford collabora0on 2017, unpublished results

slide-18
SLIDE 18

Digitized whole slide images of testicular cancer are huge gigabyte-sized files Areas of infiltrating immune cells detected by automated analysis includes millions of immune cells (red areas)

Application example 3 - Quantification task

Testicular Cancer, Quantification of tumor infiltrating lymphocytes (TIL%)

FIMM – Oxford collabora0on 2017, unpublished results

slide-19
SLIDE 19

Example patient: Immune cells in testicular cancer

Automated counting result Total immune cell count = 768.349 Immune cells/square mm tumor = 4223 Details of the analysis shown in the 
 video

FIMM – Oxford collabora0on 2017, unpublished results

slide-20
SLIDE 20

Application example 4 - Quantification Task

Quantification of fat accumulation in liver cells

Consistent Accuracy and Reproducibility over large sample sets

slide-21
SLIDE 21
slide-22
SLIDE 22

Application example 5 - Quantification Task, complex background

Quantification of nerve cell bodies from rat brain tissue (Parkinson’s, Alzheimer’s) Significant time savings:

From 45 minutes to 0,5 minutes analysis

Unforeseen Accuracy & Reproducibility

slide-23
SLIDE 23

Application example 6 - Identification of rare targets

Detection of Malaria infection in red blood cells

slide-24
SLIDE 24
slide-25
SLIDE 25

Examples of performed Deep Learning Image Analysis Applications

Breast cancer biomarkers: ER, Ki67, HER2 + Epithelium/stroma segmentation Prostate cancer: Gland and epithelium segmentation Lung cancer, mouse tissue: Tumor burden, tumor classification, TIL% Seminoma: TIL% Liver biopsies: Hepatosteatosis Rat brain: Nerve cell bodies (Parkinsons, ALS research) Forensic pathology: sperm detection from smears Blood: RBC, WBC, Platelets, Malaria parasites etc.

slide-26
SLIDE 26

Browser-based Fluorescence Viewer

slide-27
SLIDE 27
slide-28
SLIDE 28

WebMicroscope - Intelligent Cloud Platform

Advanced Image Storage and Collaboration tools in Cloud

Compatibility Efficient compression

Deep Learning Algorithms & Cloud computing

No local hardware Indefinite possibilities for algorithms

Disruptive business model

Affordable SaaS model for all sizes of projects

slide-29
SLIDE 29

The Future of Pathology is Digital

Supportive data for decision making -> Prognosis -> Suggesting treatment -> Faster, more accurate diagnosis and cure

slide-30
SLIDE 30

Johan Lundin MD, CSO Co-Founder Board Member Mikael Lundin MD, Chief Data Scientist Co-Founder Board Member Kari Pitkänen Business Development Co-Founder Board Member Mikael Jääskeläinen Sales Manager Kaisa Helminen CEO Tuomas Ropponen CTO Sartorius Thermo Scientific Finnzymes Sartorius Fisher Scientific Finnzymes FIMM Fisher Scientific Finnzymes, co- founder, sold to Thermo Fisher Scientific in 2010 FIMM Karolinska Institute HUS FIMM University of Helsinki Outotec Biohit Delta-Enterprise Previously: Antti Merivirta Marketing Manager 360Visualizer Testure Finland

Experienced Core Team

Combination of life science entrepreneurs, software development and machine vision experts & recognized scientists.

slide-31
SLIDE 31

Contact

Kaisa Helminen, CEO +358 40 679 0669 kaisa.helminen@fimmic.com www.webmicroscope.com @kaisa_helminen